ArticleNeurology. Clinical practice2025

Efficacy and Tolerability of Anti-CGRP Monoclonal Antibodies in Patients Aged ≥ 65 Years With Daily or Nondaily Migraine.

Amira Salim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.